Prevention and treatment strategies for arrhythmogenic cardiomyopathy
Part of Heart & circulation clinical trials.
This trial evaluates early prevention and treatment strategies for arrhythmogenic cardiomyopathy (ACM), a heart condition that can cause abnormal heart rhythms. It aims to improve care by using advanced tests like heart imaging and genetic sequencing to guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with arrhythmogenic cardiomyopathy (ACM) using heart ultrasound, ECG, MRI, biopsy, or genetic testing.
- You or your family agree to join the study and sign a consent form.
- Your medical records are complete enough for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with a genetic heart muscle condition called cardiomyopathy, which can cause irregular heartbeats. By studying your condition, doctors hope to better understand how it develops, how to predict its course, and how to improve diagnosis and treatment.
This study follows people with a confirmed PKP2 genetic mutation and arrhythmogenic cardiomyopathy (ACM) to understand how their condition changes over time. It may help doctors learn more about the disease and plan future treatments.
This trial tests a medication called tideglusib to see if it can reduce extra heartbeats in people with a genetic form of arrhythmogenic cardiomyopathy. It may help stabilize the heart's rhythm and slow disease progression.
This trial tests if a common cholesterol medicine, atorvastatin, can slow the progression of arrhythmogenic cardiomyopathy, a genetic heart condition that can cause abnormal heart rhythms. If you have this condition, joining this study may help researchers find a new way to protect your heart.
This study looks at whether a special type of defibrillator that sits under the skin is a good option for people with arrhythmogenic cardiomyopathy, a heart condition that can cause dangerous heart rhythms. It aims to help doctors decide who might benefit from this device and when.
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
Hear when a new Arrhythmogenic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.